Skip to main content
Top
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2024

Open Access 01-12-2024 | COVID-19 | Research

The pattern of neurological disorders requiring hospitalization during the COVID-19 era: an experience from Fayoum University Hospital, Egypt

Authors: Sayed S. Sayed, Mohamed El-Sayed El-Khatib, Mohamed Abdelghaffar, Fatma Elzahraa Osman Metwally, Asmaa Younis ElSary, Lamiaa I. Daker

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2024

Login to get access

Abstract

Background

Coronavirus was primarily discovered in December 2019, causing pneumonia and severe acute respiratory syndrome. It was reported several neurological symptoms associated with COVID-19. Both the central and peripheral nervous systems could be affected which might result in a higher mortality rate in hospitalized patients. This study aimed to determine the spectrum of neurological clinical presentations among patients admitted to Fayoum University Hospital before, during, and after the COVID-19 era and to examine the influence of COVID-19 vaccines mandated by the Egyptian government on neurological disorders.

Methods

This is a historical cohort study that was conducted on patients admitted to the Neurology Department at Fayoum University Hospital before, during, and after COVID-19 outbreaks from January 1st, 2018, to July 31, 2022. All participants had undergone thorough history taking and neurological examination and the necessary investigations according to the suspected diagnosis. All hospitalized patients during the COVID-19 pandemic were positive for the virus, as determined by either a positive rapid antigen test or a positive real-time reverse transcription polymerase chain reaction (RT-PCR).

Results

It was shown that the patients hospitalized during the COVID-19 era were notably older, smokers, and diabetic in comparison to other groups. Cerebrovascular disorders were more prevalent in the COVID-19 pandemic. Surprisingly, compared to prior times, individuals with autoimmune-mediated neurological diseases had higher hospitalization rates than those with other neurological disorders. Patients who were not vaccinated reported more vascular complications than those who got them. However, patients who received vaccination exhibited significantly higher neurological complications as regards, exacerbation of paroxysmal disorders.

Conclusion

It was concluded that the frequency of hospitalizations with cerebrovascular disorders and autoimmune-mediated illnesses was significantly influenced during the pandemic era. Although COVID-19 vaccinations have potential adverse effects, they have played a crucial role in preventing serious neurological problems.
Literature
1.
go back to reference Tsivgoulis G, Palaiodimou L, Katsanos AH, Caso V, Köhrmann M, Molina C, et al. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord. 2020;13. Tsivgoulis G, Palaiodimou L, Katsanos AH, Caso V, Köhrmann M, Molina C, et al. Neurological manifestations and implications of COVID-19 pandemic. Ther Adv Neurol Disord. 2020;13.
3.
go back to reference Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19. Neurology. 2021;97(23):E2269–81.CrossRefPubMedPubMedCentral Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19. Neurology. 2021;97(23):E2269–81.CrossRefPubMedPubMedCentral
4.
go back to reference Shellhaas RA. Neurologists and COVID-19: a note on courage in a time of uncertainty. Neurology. 2020;94(20):855–7.CrossRefPubMed Shellhaas RA. Neurologists and COVID-19: a note on courage in a time of uncertainty. Neurology. 2020;94(20):855–7.CrossRefPubMed
5.
go back to reference Stevens RD, Nyquist PA. Types of brain dysfunction in critical illness. Neurol Clin. 2008;26(2):469–86.CrossRefPubMed Stevens RD, Nyquist PA. Types of brain dysfunction in critical illness. Neurol Clin. 2008;26(2):469–86.CrossRefPubMed
7.
go back to reference Raveendran AV. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15(1):145–6.CrossRefPubMed Raveendran AV. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15(1):145–6.CrossRefPubMed
10.
go back to reference Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.CrossRefPubMedPubMedCentral Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.CrossRefPubMedPubMedCentral
11.
go back to reference Mekkawy DA, Hamdy S, Abdel-Naseer M, Shehata HS, Halfawy Al A, Shalaby NM, et al. Neurological manifestations in a cohort of Egyptian patients with COVID-19: a prospective, multicenter, observational study. Brain Sci. 2022;12(1):74.CrossRefPubMedPubMedCentral Mekkawy DA, Hamdy S, Abdel-Naseer M, Shehata HS, Halfawy Al A, Shalaby NM, et al. Neurological manifestations in a cohort of Egyptian patients with COVID-19: a prospective, multicenter, observational study. Brain Sci. 2022;12(1):74.CrossRefPubMedPubMedCentral
12.
go back to reference Marcolino MS, Anschau F, Kopittke L, Pires MC, Barbosa IG, Pereira DN, et al. Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: findings from a large Brazilian cohort. J Neurol Sci. 2022;15:443. Marcolino MS, Anschau F, Kopittke L, Pires MC, Barbosa IG, Pereira DN, et al. Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: findings from a large Brazilian cohort. J Neurol Sci. 2022;15:443.
13.
go back to reference Travi G, Rossotti R, Merli M, D’Amico F, Chiappetta S, Giussani G, et al. Neurological manifestations in patients hospitalized with COVID-19: a retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci. 2021;53(8):2912–22.CrossRefPubMedPubMedCentral Travi G, Rossotti R, Merli M, D’Amico F, Chiappetta S, Giussani G, et al. Neurological manifestations in patients hospitalized with COVID-19: a retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci. 2021;53(8):2912–22.CrossRefPubMedPubMedCentral
14.
go back to reference Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102–11.CrossRefPubMedPubMedCentral Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102–11.CrossRefPubMedPubMedCentral
15.
go back to reference Gęca T, Wojtowicz K, Guzik P, Góra T. Increased risk of COVID-19 in patients with diabetes mellitus—current challenges in pathophysiology, treatment and prevention. Int J Environ Res Public Health. 2022;19(11):6555.CrossRefPubMedPubMedCentral Gęca T, Wojtowicz K, Guzik P, Góra T. Increased risk of COVID-19 in patients with diabetes mellitus—current challenges in pathophysiology, treatment and prevention. Int J Environ Res Public Health. 2022;19(11):6555.CrossRefPubMedPubMedCentral
16.
go back to reference Xie J, Zhong R, Wang W, Chen O, Zou Y. COVID-19 and smoking: what evidence needs our attention? Front Physiol. 2021;18:12. Xie J, Zhong R, Wang W, Chen O, Zou Y. COVID-19 and smoking: what evidence needs our attention? Front Physiol. 2021;18:12.
17.
go back to reference Fraiman P, Godeiro Junior C, Moro E, Cavallieri F, Zedde M. COVID-19 and cerebrovascular diseases: a systematic review and perspectives for stroke management. Front Neurol. 2020;5(11): 574694.CrossRef Fraiman P, Godeiro Junior C, Moro E, Cavallieri F, Zedde M. COVID-19 and cerebrovascular diseases: a systematic review and perspectives for stroke management. Front Neurol. 2020;5(11): 574694.CrossRef
18.
go back to reference Ghasemi M, Umeton RP, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N, et al. SARS-CoV-2 and acute cerebrovascular events: an overview. J Clin Med. 2021;10(15):3349.CrossRefPubMedPubMedCentral Ghasemi M, Umeton RP, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N, et al. SARS-CoV-2 and acute cerebrovascular events: an overview. J Clin Med. 2021;10(15):3349.CrossRefPubMedPubMedCentral
19.
go back to reference Zhao J, Li H, Kung D, Fisher M, Shen Y, Liu R. Impact of the COVID-19 epidemic on stroke care and potential solutions. Stroke. 2020;51(7):1996–2001.CrossRefPubMed Zhao J, Li H, Kung D, Fisher M, Shen Y, Liu R. Impact of the COVID-19 epidemic on stroke care and potential solutions. Stroke. 2020;51(7):1996–2001.CrossRefPubMed
20.
go back to reference Canavero I, Ravaglia S, Valentino F, Micieli G. Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection. Neurosci Lett. 2021;8(759): 136040.CrossRef Canavero I, Ravaglia S, Valentino F, Micieli G. Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection. Neurosci Lett. 2021;8(759): 136040.CrossRef
22.
go back to reference Ahmed JO, Ahmad SA, Hassan MN, Kakamad FH, Salih RQ, Abdulla BA, et al. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond). 2022;1:76. Ahmed JO, Ahmad SA, Hassan MN, Kakamad FH, Salih RQ, Abdulla BA, et al. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond). 2022;1:76.
23.
go back to reference Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, et al. COVID-19: review of a 21st century pandemic from etiology to neuro-psychiatric implications. J Alzheimer’s Dis. 2020;77(2):459–504.CrossRef Yamamoto V, Bolanos JF, Fiallos J, Strand SE, Morris K, Shahrokhinia S, et al. COVID-19: review of a 21st century pandemic from etiology to neuro-psychiatric implications. J Alzheimer’s Dis. 2020;77(2):459–504.CrossRef
24.
go back to reference Carlos Duran J, Pablo DJ. Post COVID-19 neurological syndrome: a prospective study at 3600 m above sea level in La Paz Bolivia. J Neurol Sci. 2021;1(429): 119820.CrossRef Carlos Duran J, Pablo DJ. Post COVID-19 neurological syndrome: a prospective study at 3600 m above sea level in La Paz Bolivia. J Neurol Sci. 2021;1(429): 119820.CrossRef
25.
go back to reference Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15(11):e0240784.CrossRefPubMedPubMedCentral Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15(11):e0240784.CrossRefPubMedPubMedCentral
26.
go back to reference Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378–83.CrossRefPubMedPubMedCentral Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378–83.CrossRefPubMedPubMedCentral
27.
go back to reference Romagnolo A, Imbalzano G, Artusi CA, Balestrino R, Ledda C, De Rosa FG, et al. Neurological comorbidities and COVID-19-related case fatality: a cohort study. J Neurol Sci. 2021;9(428): 117610.CrossRef Romagnolo A, Imbalzano G, Artusi CA, Balestrino R, Ledda C, De Rosa FG, et al. Neurological comorbidities and COVID-19-related case fatality: a cohort study. J Neurol Sci. 2021;9(428): 117610.CrossRef
28.
go back to reference Carlos CR, Gerardo MM, Jaime OG, Isauro GHL, Dios APJ, Wilmar CS, et al. Prevalence of neurological manifestations in COVID-19 and their association with mortality. Neurol Perspect. 2021;1(1):11–6.CrossRefPubMedPubMedCentral Carlos CR, Gerardo MM, Jaime OG, Isauro GHL, Dios APJ, Wilmar CS, et al. Prevalence of neurological manifestations in COVID-19 and their association with mortality. Neurol Perspect. 2021;1(1):11–6.CrossRefPubMedPubMedCentral
29.
go back to reference Hosseini R, Askari N. A review of neurological side effects of COVID-19 vaccination. Eur J Med Res. 2023;28(1):1–8.CrossRef Hosseini R, Askari N. A review of neurological side effects of COVID-19 vaccination. Eur J Med Res. 2023;28(1):1–8.CrossRef
30.
go back to reference Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. 2021;90(4):627–39.CrossRefPubMedPubMedCentral Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, et al. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. 2021;90(4):627–39.CrossRefPubMedPubMedCentral
31.
go back to reference Iba T, Levy JH, Warkentin TE. Recognizing vaccine-induced immune thrombotic thrombocytopenia. Crit Care Med. 2022;50(1):E80-86.CrossRefPubMed Iba T, Levy JH, Warkentin TE. Recognizing vaccine-induced immune thrombotic thrombocytopenia. Crit Care Med. 2022;50(1):E80-86.CrossRefPubMed
32.
go back to reference Markus HS. Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself. J Neurol Neurosurg Psychiatry. 2021;92(11):1142.CrossRefPubMed Markus HS. Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself. J Neurol Neurosurg Psychiatry. 2021;92(11):1142.CrossRefPubMed
33.
go back to reference Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa. 2021;7(2):e31–e31.CrossRef Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa. 2021;7(2):e31–e31.CrossRef
34.
go back to reference Ekizoglu E, Gezegen H, Yalınay Dikmen P, Orhan EK, Ertaş M, Baykan B. The characteristics of COVID-19 vaccine-related headache: clues gathered from the healthcare personnel in the pandemic. Cephalalgia. 2022;42(4–5):366–75.CrossRefPubMed Ekizoglu E, Gezegen H, Yalınay Dikmen P, Orhan EK, Ertaş M, Baykan B. The characteristics of COVID-19 vaccine-related headache: clues gathered from the healthcare personnel in the pandemic. Cephalalgia. 2022;42(4–5):366–75.CrossRefPubMed
35.
go back to reference Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, et al. Post COVID-19 vaccination-associated neurological complications. Neuropsychiatr Dis Treat. 2022;18:137–54.CrossRefPubMedPubMedCentral Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, et al. Post COVID-19 vaccination-associated neurological complications. Neuropsychiatr Dis Treat. 2022;18:137–54.CrossRefPubMedPubMedCentral
36.
go back to reference Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13(3):215–24.CrossRefPubMed Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13(3):215–24.CrossRefPubMed
37.
go back to reference Kohli S, Varshney M, Mangla S, Jaiswal B, Chhabra PH, Kumar V, et al. Guillain–Barré syndrome after COVID-19 vaccine: should we assume a causal link? Int J Med Pharm Case Reports. 2021;1:20–4.CrossRef Kohli S, Varshney M, Mangla S, Jaiswal B, Chhabra PH, Kumar V, et al. Guillain–Barré syndrome after COVID-19 vaccine: should we assume a causal link? Int J Med Pharm Case Reports. 2021;1:20–4.CrossRef
Metadata
Title
The pattern of neurological disorders requiring hospitalization during the COVID-19 era: an experience from Fayoum University Hospital, Egypt
Authors
Sayed S. Sayed
Mohamed El-Sayed El-Khatib
Mohamed Abdelghaffar
Fatma Elzahraa Osman Metwally
Asmaa Younis ElSary
Lamiaa I. Daker
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-024-00831-x

Other articles of this Issue 1/2024

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2024 Go to the issue